|
Volumn 46, Issue 12, 2005, Pages 1279-1287
|
Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
MESSENGER RNA;
RNA;
TUMOR MARKER;
WT1 PROTEIN;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
AGED;
ANALYTICAL EQUIPMENT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
EARLY DIAGNOSIS;
FEMALE;
GENETICS;
HUMAN;
JAPAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
MINIMAL RESIDUAL DISEASE;
MONITORING;
MULTICENTER STUDY;
POLYMERASE CHAIN REACTION;
TUMOR RECURRENCE;
ADULT;
AGED;
AGED, 80 AND OVER;
EARLY DIAGNOSIS;
FEMALE;
HUMANS;
JAPAN;
LEUKEMIA, MYELOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
MONITORING, PHYSIOLOGIC;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM, RESIDUAL;
POLYMERASE CHAIN REACTION;
REAGENT KITS, DIAGNOSTIC;
RNA, MESSENGER;
RNA, NEOPLASM;
TUMOR MARKERS, BIOLOGICAL;
WT1 PROTEINS;
|
EID: 33644941227
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|